Study Objective
The main goals of our obesity clinical trials are:
- Thorough Evaluation: Test how well GLP-1 receptor agonists help with weight loss and improve metabolic health in people with obesity.
- Careful Monitoring: Check how safe the new treatment is, including any possible side effects or negative reactions.
- Patient-Centric Outcomes: Collect information on how the treatment affects quality of life and patient satisfaction.
Study Requirements
To join our obesity clinical trials, participants need to:
- Be adults aged 18 or older.
- Have a confirmed diagnosis of obesity, with a BMI above a certain level.
- Certain health conditions, medications, or past participation in other trials may prevent some people from joining.
What Can You Expect
Participants in our obesity clinical trials can look forward to:
Screening Process:
A thorough check to see if you qualify, including reviewing medical history and lab tests.
Treatment Administration:
Receive the new GLP-1 receptor agonist therapy and have regular follow-up visits to track progress and health.
Compensation:
Possible payment for time and travel related to study visits.
Frequently Asked Questions
What do your obesity clinical trials focus on?
Our obesity clinical trials test treatments using GLP-1 receptor agonists. The goal is to find new ways to help people reach and maintain a healthier weight and improve their quality of life.
What is obesity?
Obesity is a long-term disease in which having too much body fat raises the risk of health problems such as type 2 diabetes, heart disease, and some cancers. Managing obesity is important to lower these risks and improve physical health.
What are the objectives of the study?
The study aims to test how well GLP-1 receptor agonists support weight loss and improve metabolic health, monitor the safety of the new treatment and any side effects, and collect information on how the treatment affects quality of life and patient satisfaction.
What are the study requirements?
To join, participants need to be adults aged 18 or older with a confirmed diagnosis of obesity and a BMI above a certain level. Certain health conditions, medications, or past participation in other trials may prevent some people from joining.
What can I expect from the study?
Participants can expect a thorough screening process that reviews medical history and lab tests, administration of the new GLP-1 receptor agonist therapy with regular follow-up visits, and possible compensation for time and travel related to study visits.
Volunteer Reviews
Google Based Reviews
A’m very grateful about this opportunity the staff are very professional and friendly I recommend AGA Clínica Research because they really help people to improve their lives thanks
~ Gladys Alvarez
I am very happy with the attention first of the doctor who is an excellent doctor, very kind, an excellent human being and the attention of his assistants such as the laboratory assistant..
~ Rosario Casais
Amazing service! The staff is very nice and patient with me and my family. I was seen right away. No wait time. Great experience!
~ Erika
Employees are very professional and friendly. Always able to convey the necessary information to the patient in the most accessible way.
~ Paola Allende
Very detailed and thorough in explaining. The office staff is friendly, warm and attentive.
~ Milerka Lantigua
Excellent service from the staff, the phlebotomist is very experienced and very good. The atmosphere is very pleasant and the coordinators are girls who are very attentive to everyone. The long time doctor is still here.
~ Dignora Ortega
How to Get Involved
If you or someone you know wants to join our obesity clinical trials, please contact us for more details. Our clinical trial coordinators are here to answer questions and help with the enrollment process.
Participate Today for a Better Tomorrow
Our obesity clinical trials at AGA Clinical Trials offer a great chance to improve treatment options for people dealing with obesity. Call us at (786) 326-1583 if you meet the criteria.